The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This Epilepsy – Pipeline Insight, 2021 provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Epilepsy pipeline landscape.

Epilepsy 40

Epilepsy Clinical Trials Research and Development Pharmaceutical 40

MMJ Recs

DECEMBER 28, 2023

In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

The Cannigma

JUNE 29, 2021

Though the distinction between these terms may seem trivial at first glance, it is in fact crucial for cannabis research, and therefore also for consumers and regulators as well. Researchers conducting survey based studies today often only have access to the THC concentration of the cannabis that their participants are using.

Terpenes 138

Terpenes Research and Development Cannabinoids Concentrates 138

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Today (30 May) at 09.30 Effective, most effective in treatment Relieve symptoms.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Adverse mental events were reported as well, however, more research should be performed to assess well this outcome.

Safety 52

Safety Cannabinoids Events Data 52

Canna Law Blog

JUNE 18, 2019

Second, the Committee focused on the safety of CBD itself. FDA-approved Epidiolex , the epilepsy medication that contains CBD, includes a warning about liver damage. The FDA must also preserve incentives to research CBD’s health benefits. That being said, the Committee also wants CBD in drugs.

Hemp 92

Hemp CBD Food Research and Development 92

Veriheal

JANUARY 18, 2023

The lack of regulation has raised concerns about consumer safety. Research commissioned by the Centre for Medicinal Cannabis pinned a £1 billion valuation on the CBD market by the year 2025. This rare type of epilepsy caused her to endure up to 300 grand mal seizures per week from the tender age of five. Home Office.

CBD 97

CBD Strains Research and Development Oil 97

MMJ Recs

NOVEMBER 17, 2023

Licensing fees, taxes, and other revenue sources associated with MMJ operations generate income that can be reinvested in public services, healthcare initiatives, and community development. Promoting Research and Innovation The medical marijuana industry promotes research and innovation in the field of cannabis-based therapies.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JANUARY 18, 2022

Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders, and anti-viral indications, reported positive results of four preclinical dermal safety studies for Epoladerm™ (diclofenac epolamine). Mack, Chairman and CEO of Virpax. Christopher M.

Safety 40

Safety Chronic Pain Research and Development Pharmaceutical 40

Cannabis Law Report

JANUARY 27, 2020

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59

Safety CBD Food Seed-To-Sale 59

Cannabis Law Report

NOVEMBER 10, 2021

– Multiple Contracts Awarded to Support the Development and Manufacturing of Envelta (NES100) – BERWYN, Pa.–(BUSINESS as well as to support Good Laboratory Practices (GLP) toxicology, safety studies and preclinical efficacy studies. –(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc.

Research and Development 40

Research and Development Chronic Pain Pharmaceutical Clinical Trials 40

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

GW Pharma carefully developed Epidiolex using cannabinoids to reduce the occurrence of seizures. Thanks to their diligence in perfecting the drug and ensuring its safety for intended use, the Drug Enforcement Agency scheduled Epidiolex under the lowest Schedule classification for controlled substances. Dravet Syndrome.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Veriheal

JUNE 22, 2020

This approval came after significant research into the effects of cannabis on seizure disorders. The priority was ensuring the health and safety of the baby. However, the future’s looking bright—both for Oscar Parodi and for any number of future newborns who may benefit from the treatments being developed.

Therapy 76

Therapy Treatment Research and Development Conditions 76

The Cannigma

JANUARY 16, 2023

1 Muscimol is a well-researched, natural compound and has been studied as a potential treatment for drug-resistant epilepsy, its potential effects on neurological disorders, and its pain-relieving abilities. Muscimol was the molecule used by scientists to develop numerous new pharmaceutical drugs aimed at targeting the GABA system.

Research and Development 127

Research and Development History Treatment Retail 127

MMJ Recs

MAY 25, 2024

Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. The stigma is largely due to its association with recreational use and misconceptions about its effects.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

Cannabis Law Report

MARCH 6, 2020

“Kannalife’s research has the potential to make a global impact as their growing portfolio of international patents pushes forward their go-to-market strategy.” It’s safety and efficacy have not been confirmed by FDA-approved research. This is the sixth patent grant that Kannalife has received.

Research and Development 59

Research and Development Marijuana Pharmaceutical Supply Chain 59

Cannabis Law Report

NOVEMBER 24, 2019

Recommendations for research. Severe treatment-resistant epilepsy. 1.4 Severe treatment-resistant epilepsy. NICE has made research recommendations on the use of cannabis-based medicinal products for severe treatment-resistant epilepsy. potential impact on structural and functional brain development.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

Otherside Farms

NOVEMBER 10, 2019

Autism cannot be described as a single disease but includes the entire spectrum of conditions that affect healthy mental development. Disorders of neural development manifest in them as the inability of normal communication, the absence of empathy, attention disorder, and other intellectual disabilities. Safety of Use.

Therapy 56

Therapy Research and Development Epilepsy CBD 56

WeedAdvisor

APRIL 1, 2019

CBD Oil for dogs, cats and other pets is a natural development of the cannabidiol (CBD) craze. As anecdotal evidence began piling up, some companies decided that CBD’s reported effects on epilepsy (which has been heavily proven), anxiety, insomnia, pain and inflammation – among others – could work on dogs, cats and other pets.

Pets 49

Pets Oil CBD Research and Development 49

MMJ Recs

JULY 5, 2024

Understanding THC’s mechanisms and clinical implications is crucial as researchers continue to uncover its therapeutic potential and limitations in medical settings. Neurological Disorders Research suggests THC may benefit neurological conditions such as epilepsy, multiple sclerosis (MS), and Parkinson’s disease.

THC 52

THC Research and Development Chronic Pain Cannabinoids 52

United Patients Group

JULY 29, 2024

Research has also shown that cannabis contains terpenes , aromatic compounds that contribute to its therapeutic effects. Understanding the synergy between these elements is crucial for developing a holistic approach to health. It is also vital to consider dosage and delivery methods to ensure optimal results.

Research and Development 52

Research and Development Strains Chronic Pain Medicine 52

Cannabis Law Report

JANUARY 26, 2022

The Innovation Passport does not reduce the burden of demonstrating that a treatment may be safe and effective, but does provide research organizers with expert advice, patient input, and collaboration throughout the clinical trial design and development process through a product-specific Target Development Profile. ABOUT MAPS.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Cannabis Law Report

MARCH 2, 2020

The government said it is working with industry to explore further ways to reduce costs and encourage more research into uninterrupted access to cannabis-based medicinal products where clinically appropriate. The event will bring together cannabinoid researchers from around the world and representatives from NIHR, NICE, and the DHSC.

Medicine 45

Medicine Research and Development Clinical Trials Patients 45

Cannabis Law Report

NOVEMBER 24, 2021

Published by The Journal of Cannabis Research. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

MMJ Recs

JUNE 9, 2024

Qualifying conditions include chronic or debilitating diseases, including cancer, epilepsy, multiple sclerosis, Crohn’s disease, Parkinson’s disease, and post-traumatic stress disorder (PTSD), among others.

Access 52

Access Marijuana Patients Programs 52

The Joint Blog

MARCH 21, 2021

There is evidence out there to suggest that CBD oil can be used to treat the following conditions: Epilepsy. So does the research support this? CBD Safety. Depression. Chronic pain. Cancer-related symptoms. Is CBD oil legal? Easy things to look out for include: Clear labelling with details of CBD quantity.

Safety 26

Safety CBD Oil Cannabinoids 26

Cannabis Law Report

JULY 13, 2019

The report goes on to say it believes more research is needed into cannabis prescriptions in the U.K. But it says one of the barriers to research is that industry is not always prepared to supply products for research trials. However the problem in the U.K. is such special drugs are subject to stringent guidelines.

Research and Development 40

Research and Development Clinical Trials Epilepsy Patients 40

Cannabis Law Report

DECEMBER 28, 2021

These accomplishments include accelerated development of our existing product candidates, broadening our pipeline of product candidates, and utilizing grants where appropriate. Nanomerics’) has enabled the development of product candidates for central nervous system (‘CNS’) and anti-viral indications. Mack, Chairman and CEO of Virpax.

Pharmaceutical 40

Pharmaceutical Research and Development Clinical Trials Chronic Pain 40

Cannabis Law Report

JANUARY 6, 2020

The ongoing studies and research that focuses on CBD provide a very clear picture of how this compound can provide some health benefits relating to seizures, cancer, anxiety, pain, and inflammation. Some research studies have linked the endocannabinoid system has to the pathogenesis of autism. The Safety of CBD.

Oil 59

Oil CBD Sleep Research and Development 59

MMJ Recs

MARCH 14, 2024

These conditions include, but are not limited to, cancer, epilepsy, multiple sclerosis, and PTSD, among others. Moreover, dispensaries must implement robust security measures to prevent theft and ensure patient safety. These standards encompass various aspects of testing, including potency, purity, and contaminants.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

Greenspoon Marder Cannabis Law Group Blog

APRIL 2, 2019

For example, we’re seeking comments, data and information on a variety of topics including: what levels of cannabis and cannabis-derived compounds cause safety concerns; how the mode of delivery (e.g.,

CBD 40

CBD Research and Development Safety Therapy 40

Cannabis Law Report

JANUARY 27, 2022

However, one possible pro of New York’s medical approach is the focus on research. A psilocybin research licensee could also contract with a university or hospital within the University of New York system and conduct joint research projects. Shared Traits of Each Approach. You can contact Brett Mulligan at ? info@gl-lg.com ?

Legalization 52

Legalization Research and Development Legislation Treatment 52

Cannabis Law Report

JUNE 26, 2019

She researches substituting cannabis for opioids in chronic pain management at Nova Southeastern University and Florida International University. He is currently the Director of Business Development at Kaycha Group, which owns and operates EVIO Labs Florida, ISO accredited cannabis testing labs, and the MJ Buddy App. Zachary Kobrin.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

The Cannigma

DECEMBER 22, 2021

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. Today’s guest is Itai Rogel, the Vice President of Business Development at Israeli cannabis company, Bazelet. Music by Desca.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

JUNE 1, 2021

Drake is well-known as an inspiring and inclusive leader who is dedicated to the development of her teams and solely focused on organizational success for the benefit of patients. Company remains on track for potential approval of Vicineum™ in the US in August 2021. CAMBRIDGE, Mass.–(BUSINESS

Research and Development 51

Research and Development Treatment Pharmaceutical Patients 51